<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Compliance Policy Guide Sec. 400.400 Conditions Under Which Homeopathic Drugs May Be Marketed; Withdrawal of Guidance</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Compliance Policy Guide Sec. 400.400 Conditions Under Which Homeopathic Drugs May Be Marketed; Withdrawal of Guidance</h1>
    <p class="timestamp">Published: 2019-10-25 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the withdrawal of Compliance Policy Guide Sec. 400.400 (CPG 400.400) entitled "Conditions Under Which Homeopathic Drugs May be Marketed," which was issued in 1988.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-23334</p>
    <p><strong>Publication Date:</strong> 2019-10-25</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/10/25/2019-23334/compliance-policy-guide-sec-400400-conditions-under-which-homeopathic-drugs-may-be-marketed">https://www.federalregister.gov/documents/2019/10/25/2019-23334/compliance-policy-guide-sec-400400-conditions-under-which-homeopathic-drugs-may-be-marketed</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-23334</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
